ATE110113T1 - Kristallines r-h-gm-csf und verfahren zur herstellung. - Google Patents

Kristallines r-h-gm-csf und verfahren zur herstellung.

Info

Publication number
ATE110113T1
ATE110113T1 AT90306042T AT90306042T ATE110113T1 AT E110113 T1 ATE110113 T1 AT E110113T1 AT 90306042 T AT90306042 T AT 90306042T AT 90306042 T AT90306042 T AT 90306042T AT E110113 T1 ATE110113 T1 AT E110113T1
Authority
AT
Austria
Prior art keywords
csf
crystalline
production
preparing
molecular weight
Prior art date
Application number
AT90306042T
Other languages
English (en)
Inventor
Paul Reichert
Gerald S Hammond
Hung V Le
Tattanahali L Nagabhushan
Paul P Trotta
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE110113T1 publication Critical patent/ATE110113T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/145—Colony stimulating factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Glass Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
AT90306042T 1989-06-06 1990-06-04 Kristallines r-h-gm-csf und verfahren zur herstellung. ATE110113T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/362,187 US5109119A (en) 1989-06-06 1989-06-06 Crystalline r-h-gm-csf and method

Publications (1)

Publication Number Publication Date
ATE110113T1 true ATE110113T1 (de) 1994-09-15

Family

ID=23425041

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90306042T ATE110113T1 (de) 1989-06-06 1990-06-04 Kristallines r-h-gm-csf und verfahren zur herstellung.

Country Status (14)

Country Link
US (2) US5109119A (de)
EP (3) EP0402070B1 (de)
JP (1) JP2572160B2 (de)
KR (1) KR960004454B1 (de)
AT (1) ATE110113T1 (de)
AU (1) AU644083B2 (de)
CA (1) CA2058441C (de)
DE (1) DE69011586T2 (de)
DK (1) DK0402070T3 (de)
FI (1) FI915709A0 (de)
HK (1) HK184996A (de)
HU (1) HU209871B (de)
NO (1) NO914771D0 (de)
WO (1) WO1990015151A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU637133B2 (en) * 1989-08-11 1993-05-20 Amrad Operations Pty. Limited Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
EP0955365A3 (de) 1992-06-09 2000-12-20 Chiron Corporation Kristallisierung von M-CSF
US5581476A (en) * 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
US6004549A (en) * 1994-12-14 1999-12-21 Schering Corporation Crystalline protein controlled release compositions
US6555660B2 (en) * 2000-01-10 2003-04-29 Maxygen Holdings Ltd. G-CSF conjugates
US6646110B2 (en) * 2000-01-10 2003-11-11 Maxygen Holdings Ltd. G-CSF polypeptides and conjugates
US6831158B2 (en) * 2000-01-10 2004-12-14 Maxygen Holdings Ltd. G-CSF conjugates
PE20020394A1 (es) * 2000-08-18 2002-06-21 Agouron Pharma Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
IL159524A0 (en) * 2001-07-11 2004-06-01 Maxygen Holdings Ltd G-csf conjugates
US7765302B2 (en) * 2003-06-30 2010-07-27 Nortel Networks Limited Distributed call server supporting communication sessions in a communication system and method
AU2005275108B2 (en) * 2004-07-16 2011-05-12 Nektar Therapeutics Conjugates of a GM-CSF moiety and a polymer
US7381805B2 (en) 2005-06-01 2008-06-03 Maxygen Holdings, Ltd. Compositions comprising mixtures of positional PEG isomers of PEGylated G-CSF
WO2007102946A2 (en) * 2006-01-23 2007-09-13 Amgen Inc. Crystalline polypeptides
EP3079668A1 (de) 2013-12-09 2016-10-19 Durect Corporation Pharmazeutisch aktive wirkstoffkomplexe, polymerkomplexe und zusammensetzungen und verfahren damit

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
ZA858833B (en) * 1984-11-20 1986-06-25 Schering Biotech Corp Cdna clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophil cellular growth factor activity
JP2595216B2 (ja) * 1986-12-12 1997-04-02 日清製粉株式会社 α―アミラーゼインヒビターの結晶の製造方法
US4912200A (en) * 1987-05-11 1990-03-27 Schering Corporation Extraction of granulocyte macrophage colony stimulating factor from bacteria
ATE118544T1 (de) * 1988-05-31 1995-03-15 Cetus Oncology Corp Verfahren zur gewinnung von heterologe proteine enthaltenden refraktilkörpern aus mikrobiellen wirten.

Also Published As

Publication number Publication date
US5616555A (en) 1997-04-01
HK184996A (en) 1996-10-11
AU644083B2 (en) 1993-12-02
KR960004454B1 (ko) 1996-04-06
FI915709A7 (fi) 1991-12-04
JP2572160B2 (ja) 1997-01-16
FI915709A0 (fi) 1991-12-04
US5109119A (en) 1992-04-28
WO1990015151A1 (en) 1990-12-13
HU209871B (en) 1994-11-28
DE69011586T2 (de) 1995-03-02
EP0402070A1 (de) 1990-12-12
EP0476022A1 (de) 1992-03-25
AU5834890A (en) 1991-01-07
NO914771L (no) 1991-12-04
KR920700293A (ko) 1992-02-19
HUT58822A (en) 1992-03-30
NO914771D0 (no) 1991-12-04
CA2058441C (en) 1997-12-16
HU904835D0 (en) 1992-02-28
EP0402070B1 (de) 1994-08-17
JPH04502014A (ja) 1992-04-09
DK0402070T3 (da) 1994-09-12
DE69011586D1 (de) 1994-09-22
EP0561429A1 (de) 1993-09-22
CA2058441A1 (en) 1990-12-07

Similar Documents

Publication Publication Date Title
ATE110113T1 (de) Kristallines r-h-gm-csf und verfahren zur herstellung.
DE68922726D1 (de) Medizinisches material und verfahren zur herstellung.
NZ222888A (en) Resorbable implant of foam-like polyester-based plastic material
PT81168A (de) Blutgerinnungshemmende proteine verfahren zur herstellung sowiederen verwendung
DE69125035D1 (de) Verfahren zur herstellung von interferon-alpha-2 kristallen
DE59107966D1 (de) Hohlnadel zur medizinischen verwendung und verfahren zur herstellung derartiger hohlnadeln
DE68928482D1 (de) Verfahren zur Herstellung eines Bipolartransistors
DE69217198D1 (de) Saugnapf und verfahren zur herstellung desselben
FI865186L (fi) Menetelmä ihmisen granulosyyttien-makrofagien pesäkkeitä stimuloiva tekijä -proteiinien valmistamiseksi
DE69133492D1 (de) Rekombinanter menschlicher Hepatozytwachstumsfaktor und Verfahren zu seiner Herstellung
ATE79545T1 (de) Verwendung vom ''cartilage-inducing faktor b(cif- b)'' zur herstellung eines arzneimittels gegen das wachstum von tumoren.
ATE71658T1 (de) Verfahren zur herstellung von humanlysozym.
DE69427955D1 (de) Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern
IT1223099B (it) Procedimento per l'iniettofusione di materie artificiali termoplastiche
DE3784518D1 (de) Medizinisches material und verfahren zur herstellung.
ATA293786A (de) Mischung zur herstellung von formkoerpern sowie deren verwendung und daraus gebildete formkoerper
ATA909285A (de) Verfahren zur herstellung von hautpflegenden kompositionen mit keratolytischer und entzuendungshemmender wirkung
ATA163789A (de) Verfahren zur herstellung von keramischen formteilen
AT389514B (de) Verfahren zur herstellung von neuen purinderivaten und ihren salzen
DE3879063D1 (de) Keramikbasis sowie verfahren zur herstellung.
DE68928787D1 (de) Verfahren zur Herstellung eines Bipolartransistors
DE3586940D1 (de) Polypeptid und dessen verfahren zur herstellung.
DE3673976D1 (de) Verfahren zur herstellung von polyparaphenylenfilmen und verwendungen dieser filme.
ATA327685A (de) Verfahren zur herstellung eines neuen lymphokins (lk 2) sowie verwendung von lk 2 zur herstellung eines pharmazeutischen praeparates
DE69115325D1 (de) Rekombinantes Plasmid für die Expression von Lipase und Verfahren zur Herstellung von Lipase

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee